MEDIA
PDC Therapeutics building better docetaxel therapy with nanocarrier technology
Prof. Rana Sanyal won the European Prize for Women Innovators
Cancer Drug Clears Phase 1 Trials
A historic milestone in cancer drug development
Cover Story – The Business Leaders of Science: Smart fight against cancer
RS Research was listed 13th in Fast Company’s 50 Most Innovative Companies 2024
Turkish biotech bags $12M for targeted delivery of cancer drugs
RS Research has raised $12M in Series-A investment round with GEN Ilac as the lead investor
Turkey’s first new drug started phase-I clinical study
Turkey’s Promising biotech startup raises $12M in Series A Investment Round
From Bench to Bedside: first ever in Turkey
RS Research was listed in among the most successful startups in Forbes’ 2025 Startup 50!
Investments in start-up ecosystem
13th Technology Awards by TUBITAK, TTGV and TUSIAD
Turkey’s new locally made cancer drug counts down to launch
Cancer Drug Clears Phase 1 Trials
PDC Therapeutics building better docetaxel therapy with nanocarrier technology
Turkish biotech bags $12M for targeted delivery of cancer drugs
Turkey’s Promising biotech startup raises $12M in Series A Investment Round
Interview with Rana Sanyal: The Future of Nanomedicines
Big Business Through Cultural Cooperation Between Turkey and The US: “Move Turkey To Forward in Health
VC Funded RS Research starting Clinical Trials
